Alim stock price target

ALIM | Alimera Sciences Inc. Analyst Estimates | MarketWatch

ALIM Stock Price | Alimera Sciences Inc. Stock Quote (U.S ... ALIM | Complete Alimera Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ALIM | Alimera Sciences Inc. Analyst Estimates | MarketWatch Nov 08, 2019 · Alimera Sciences Inc. analyst estimates by MarketWatch. View ALIM revenue estimates and earnings estimates, as well as analyst recommendations.

Alimera Sciences Plans Reverse Stock Split to Boost Share Price in Line With Nasdaq Rules 9:09AM ET 9/05/2019 MT Newswires. Alimera Sciences (ALIM) said its board approved a reverse split of its common stock to allow the pharmaceutical company to attain the minimum $1 per share

ALIM nearly doubled in price in 6 trading days this month. After retracing 61.8% of this move, ALIM broke out of its' narrow channel flag with decent volume. If we see follow through ALIMs' first target is 8.29. ALIM Stock Quote - Alimera Sciences, Inc. Common Stock ... Stock quote for Alimera Sciences, Inc. Common Stock Common Stock (ALIM) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Alimera Sciences Inc. Stock Price (ALIM) | Barron's Mar 31, 2020 · View today's stock price, news and analysis for Alimera Sciences Inc. (ALIM). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and

2 hours ago · Alimera Sciences (NASDAQ:ALIM) had its price target lowered by B. Riley from $24.00 to $15.00 in a research report released on Tuesday morning, BenzingaRatingsTable reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also recently issued reports on the stock.

ALIM - Alimera Sciences, Inc. Summary, Stock ... - Benzinga Jan 01, 2010 · Alimera Sciences, Inc. (NASDAQ: ALIM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers

Stock analysis for Alimentation Couche-Tard Inc (ATD/B:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

ALIM Stock Quote - Alimera Sciences, Inc. Common Stock ... Stock quote for Alimera Sciences, Inc. Common Stock Common Stock (ALIM) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Alimera Sciences Inc. Stock Price (ALIM) | Barron's Mar 31, 2020 · View today's stock price, news and analysis for Alimera Sciences Inc. (ALIM). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Stock Comparison: Compare Alimera Sciences, Inc. (ALIM) to ...

ALIMERA SCIENCES (NASDAQ:ALIM) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ALIMERA SCIENCES | Nasdaq: ALIM | Nasdaq. Average target price, 25,31 $. Last Close Price, 4,75 $.

Stock quote for Alimera Sciences, Inc. Common Stock Common Stock (ALIM) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Alimera Sciences Inc. Stock Price (ALIM) | Barron's Mar 31, 2020 · View today's stock price, news and analysis for Alimera Sciences Inc. (ALIM). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Stock Comparison: Compare Alimera Sciences, Inc. (ALIM) to ...

Alimera Sciences Inc (NASDAQ:ALIM) price target set to $3 ... Nov 07, 2018 · Today, HC Wainwright set its price target on Alimera Sciences Inc (NASDAQ:ALIM) to $3.00 per share. There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. Alimera Sciences, Inc. (ALIM) Stock Price, Quote, History ... Alimera Sciences Appoints Steven T. Gill to the Newly Created Position of Vice President, Thought Leader Engagement. Alimera Sciences, Inc. (ALIM), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it has appointed Steven T. Gill as Vice President, Thought Leader Engagement. NASDAQ:ALIM Alimera Sciences, Inc. Stock Analysis ...